• Diálogo Awards Prize to CNIO and Institut Curie
  05.05.2014
  The Spanish National Cancer Research Centre (CNIO) and the Institut Curie have been awarded the 11th Diálogo Prize for Franco?Hispanic Friendship in recognition for their world-leading contributions to the prevention, diagnosis and treatment of cancer. Maria Blasco, Director of the CNIO, and Thierry Philip, President of the Institut Curie will receive the award at the […]
• CNIO and the Roche Institute will bring advances in hereditary cancer closer to different professional groups
  30.04.2014
  With the aim of improving knowledge and care of hereditary cancer in primary health care system, the Spanish National Cancer Research Centre (CNIO) and the Roche Institute have reached a specific collaboration agreement that will serve to implement an ambitious training programme. The agreement, which is included within a broad, well-established framework of understanding between […]
• CNIO team presents a new strategy to personalize cancer therapies
  29.04.2014
  Tumour cells can accumulate hundreds or even thousands of DNA mutations which induce the growth and spread of cancer. The number and pattern of mutations differs according to the type of tumour, even among those that are classified as part of the same type of tumours. This complexity, which researchers were not aware of just […]
• A protein required for integrity of induced pluripotent stem cells
  17.04.2014
  Cell reprogramming converts specialised cells — such as nerve cells or skin cells — towards an embryonic stem cell state. This reversal in the evolutionary development of cells also requires a reversal in the biology of telomeres, the structures that protect the ends of chromosomes; whilst under normal conditions telomeres shorten over time, during cell […]
• International consortium discovers two new genes that modulate risk of breast and ovarian cancer
  04.04.2014
  Today we know that women carrying BCRA1 and BCRA2 gene mutations have a 43%–88% risk of developing from breast cancer before the age of 70. Taking critical decisions such as opting for preventive surgery when the risk bracket is so wide is not easy. Spanish National Cancer Research Centre (CNIO) researchers are conducting a study […]
• CNIO-Merck alliance receives prize from ‘Correo Farmacéutico’
  18.03.2014
  Once more, Correo Farmacéutico, one of the most prestigious Spanish journals in the health field, has selected the winners for the Best Initiatives in Pharmacy of 2013. In this year’s awards, the alliance between CNIO and the pharmaceutical company Merck has received an award as one of the best initiatives in the Pharmacological Research and […]
• CNIO team explains lower cancer incidence rate in patients experiencing brain and nervous system diseases
  20.02.2014
  Epidemiological studies demonstrate that diseases of the central nervous system such as Alzheimer, Parkinson and schizophrenia protect against cancer. The most remarkable example is Alzheimer’s disease, which can reduce the risk of suffering from cancer by up to 50%. Various theories have been put forward in an attempt to explain this relationship between diseases that […]
• A CNIO study finds a ‘molecular scaffolding’ that maintains skin structure and organisation
  16.01.2014
  The human body is daily exposed to external assaults such as bacteria, ultraviolet light or chemical agents. Skin, the largest organ of the body, is the first line of defense against these agents. Skin performs this function thanks to the close connections established between its cells (e.g. adherens junctions). The loss of cell adhesion between […]
• Seve Ballesteros Foundation visits CNIO
  20.12.2013
  Carmen Ballesteros, daughter of the legendary golfer Severiano Ballesteros, visited the Spanish National Cancer Research Centre (CNIO) yesterday, on behalf of the Seve Ballesteros Foundation and donated a cheque for 100,000 euros. CNIO will destine this amount to support brain tumour research in the laboratory of Massimo Squatrito, Head of the Seve-Ballesteros Foundation Brain Toumour […]